These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32015791)
1. Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present. Gray C; Cooke CE; Brandt N Am Health Drug Benefits; 2019 Sep; 12(5):243-251. PubMed ID: 32015791 [TBL] [Abstract][Full Text] [Related]
2. Trends in Medicare Part D Medication Therapy Management Eligibility Criteria. Wang J; Shih YC; Qin Y; Young T; Thomas Z; Spivey CA; Solomon DK; Chisholm-Burns M Am Health Drug Benefits; 2015; 8(5):247-55. PubMed ID: 26380030 [TBL] [Abstract][Full Text] [Related]
3. Online Provision of Part D Medication Therapy Management Program Information. Tong Z; Cooke CE; Brandt NJ J Manag Care Spec Pharm; 2019 Aug; 25(8):898-903. PubMed ID: 31347982 [TBL] [Abstract][Full Text] [Related]
4. Medicare medication therapy Management: Beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013 to 2016). Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC J Am Pharm Assoc (2003); 2024; 64(5):102140. PubMed ID: 38825153 [TBL] [Abstract][Full Text] [Related]
5. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial. Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population. Lee JS; Yang J; Stockl KM; Lew H; Solow BK J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models. Miller DE; Roane TE; Salo JA; Hardin HC J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280 [TBL] [Abstract][Full Text] [Related]
8. Survey of medication therapy management programs under Medicare part D. Touchette DR; Burns AL; Bough MA; Blackburn JC J Am Pharm Assoc (2003); 2006; 46(6):683-91. PubMed ID: 17176683 [TBL] [Abstract][Full Text] [Related]
9. Should eligibility for medication therapy management be based on drug adherence? Stuart B; Loh E; Miller L; Roberto P J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767 [TBL] [Abstract][Full Text] [Related]
11. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria. Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303 [TBL] [Abstract][Full Text] [Related]
12. Navigating Medicare Part D Websites: Are the Part D Plans in Compliance? Cooke CE; Kaiser MJ; Sheppard MA; Brandt NJ J Gerontol Nurs; 2016 Oct; 42(10):9-14. PubMed ID: 27668439 [TBL] [Abstract][Full Text] [Related]
13. Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry. Spinler SA; Cziraky MJ; Tang F; Dueñas GG; Thomas T; Reinhold JA; Willey VJ Am Health Drug Benefits; 2013 Sep; 6(7):367-74. PubMed ID: 24991369 [TBL] [Abstract][Full Text] [Related]
14. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format. Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816 [TBL] [Abstract][Full Text] [Related]
15. Factors affecting demand among older adults for medication therapy management services. Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238 [TBL] [Abstract][Full Text] [Related]
16. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries. Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497 [TBL] [Abstract][Full Text] [Related]
17. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services. Shoemaker SJ; Hassol A J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results. O'Shea TE; Zarowitz BJ; Erwin WG J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922 [TBL] [Abstract][Full Text] [Related]
19. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. Fox D; Ried LD; Klein GE; Myers W; Foli K J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345 [TBL] [Abstract][Full Text] [Related]
20. Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor. Stuart B; Hendrick FB; Shen X; Dai M; Tom SE; Dougherty JS; Miller LM Health Aff (Millwood); 2016 Sep; 35(9):1572-80. PubMed ID: 27605635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]